Área Sanitaria de Lugo, A Mariña e Monforte De Lemos
Área sanitaria
Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (65)
2024
-
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Scientific reports, Vol. 14, Núm. 1, pp. 12726
-
Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools
Archivos de Bronconeumologia
-
Dispersal history of SARS-CoV-2 in Galicia, Spain
Journal of Medical Virology, Vol. 96, Núm. 7
-
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study
Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315
-
Primary Care Referral Delays in Oral Cancer Diagnosis: A Meta-Analysis
Oral Diseases
-
The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study
Inflammopharmacology, Vol. 32, Núm. 6, pp. 3697-3705
2023
-
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study
Journal of Medical Virology, Vol. 95, Núm. 7
2022
-
Diabetes mellitus and oral lichen planus: A systematic review and meta-analysis
Oral Diseases, Vol. 28, Núm. 8, pp. 2100-2109
-
Risk factors for chronic obstructive pulmonary disease in never-smokers: A systematic review
Clinical Respiratory Journal, Vol. 16, Núm. 4, pp. 261-275
2021
-
Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project
Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10
2020
-
Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 662-669
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
-
Organización del control de la tuberculosis en España: evaluación de una estrategia dirigida a fomentar la acreditación de unidades de tuberculosis
Archivos de bronconeumologia, Vol. 56, Núm. 2, pp. 90-98
-
Use of Magnetic Resonance Imaging in the Evaluation of Mediastinal and Systemic Disease in Lymphoma. A Systematic Review
Open Respiratory Archives, Vol. 2, Núm. 3, pp. 151-157
2019
-
Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360
-
Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project
Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739
2018
-
Backpack weight and back pain reduction: effect of an intervention in adolescents
Pediatric Research, Vol. 84, Núm. 1, pp. 34-40
-
Cardiovascular risk stratification in axial spondyloarthritis: Carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients
Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 73-80